跳至主要内容
临床试验/JPRN-UMIN000025222
JPRN-UMIN000025222已完成未知

Evaluation of the effect of magnesium oxide on the pharmacokinetics of levodopa/carbidopa - pharmacokinetic interaction between levodopa/carbidopa and magnesium oxide

Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University0 个研究点目标入组 10 人开始时间: 2016年12月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 45years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • The investigators must ensure that all subjects being considered meet the following exclusion criteria or conditions: 1) history of allergy to any drugs 2) medical attention within 2 months prior to participation 3) donation of 200 mL or more of blood within 4 weeks prior to participation, or donation of component blood within 2 weeks prior to participation 4) donation of 400 mL or more of blood within 12 weeks prior to participation 5) recent (past 4 months) participation in other clinical trial for investigational new chemical entity 6) history of drug abuse 7) alcohol abuse. 8) taking drugs or healthy foods which may affect drug metabolism

研究者

发起方
Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University

相似试验